In the eastern reaches of Congo and Uganda, an Ebola strain for which no approved vaccine exists has claimed more than 200 lives from nearly 900 confirmed cases — a toll that almost certainly understates the true weight of the crisis. Against this backdrop, Africa CDC Director-General Jean Kaseya has issued not a plea but a reckoning: a continent that produces less than one percent of its own vaccines cannot continue to place its survival in the hands of distant partners. The outbreak is a medical emergency, but it is also a mirror held up to decades of structural dependency — and Africa's lea
Africa CDC Pushes Self-Reliance as Ebola Outbreak Spreads in Congo, Uganda
We don't want to be a continent begging every day
Why is Kaseya framing this as a moment for Africa to build its own capacity rather than just asking for more international help right now?
Because the help is never enough and it never arrives fast enough. He's saying that if Africa had invested in vaccine manufacturing decades ago, this outbreak would look completely different. The dependency is the real crisis.
But people are dying now. Doesn't that take priority over long-term capacity building?
Both things are true at once. You need to stop the bleeding today and build the hospital for tomorrow. The frustration is that Africa keeps choosing between them instead of doing both.
What's different about the Bundibugyo virus that makes this outbreak harder to control?
There's no vaccine for it. Congo has dealt with Ebola before, but always the Zaire strain. This time they're working without a proven tool. It's like fighting a fire with a hose you've never used.
The 35,000 untraced contacts—how does that change the trajectory of the outbreak?
It means the peak hasn't come yet. Every untraced person is a potential chain of transmission you don't see until it's too late. That's why Kaseya said the worst is still ahead.
Is the money being pledged actually going to change anything?
It helps, but money alone doesn't build manufacturing capacity or train a workforce or establish supply chains. It's necessary but not sufficient. The real question is whether African governments will keep funding this when the headlines fade.
Der Puls
- The Bundibugyo Ebola strain — with no approved vaccine or treatment — has spread to 894 confirmed cases since mid-May, with health workers burying infants in Ituri province while being attacked by the very communities they are trying to protect.
- Contact tracing is dangerously incomplete, with over 35,000 potentially exposed individuals still unaccounted for and the identity of the outbreak's first case still unknown — meaning the peak has not yet arrived.
- Africa CDC's director-general has framed the crisis as proof that a continent producing less than 1% of its vaccines and 3% of its medicines is structurally unequipped to defend itself, calling dependency a choice that must be unmade.
- The newly established African Epidemic Fund has secured $80 million in pledges from African governments, while a broader international donor conference this week generated approximately $910 million in commitments.
- South African President Ramaphosa is set to visit both Ituri and Uganda next week to help mobilize resources, but vaccine availability by year-end remains uncertain as the outbreak continues to outpace containment efforts.
In the eastern reaches of Congo and Uganda, an Ebola strain for which no approved vaccine exists has claimed more than 200 lives from nearly 900 confirmed cases — a toll that almost certainly understates the true weight of the crisis. Against this backdrop, Africa CDC Director-General Jean Kaseya has issued not a plea but a reckoning: a continent that produces less than one percent of its own vaccines cannot continue to place its survival in the hands of distant partners. The outbreak is a medical emergency, but it is also a mirror held up to decades of structural dependency — and Africa's leadership is now insisting on a different reflection.
In eastern Congo and Uganda, Ebola has confirmed itself in 894 people and killed more than 200 since mid-May — and the real toll is almost certainly higher, as the outbreak went unrecognized for weeks before any alarm was raised. Health workers in Ituri province are burying bodies daily, including those of infants, while facing attacks from communities gripped by fear and distrust. The machinery of containment is straining against both the virus and the skepticism surrounding it.
This is the crisis that Africa CDC Director-General Jean Kaseya is using to make a harder argument. Speaking in Addis Ababa, he described the outbreak as the worst the continent has faced at this stage of its spread — and then turned the lens inward. If this were happening in Europe or North America, he said, a vaccine would already exist. The difference is not biology. It is investment and will. Africa produces less than one percent of the vaccines it needs and three percent of its medicines. 'We don't want to be a continent begging every day,' he said.
The outbreak is complicated by the fact that it is caused by the Bundibugyo strain of Ebola, for which no approved vaccine or treatment exists. Congo has survived sixteen Ebola outbreaks before, but most involved the Zaire strain, which has a vaccine. This time, the continent is improvising. More than 35,000 contacts remain untraced. The index case has not been identified. The peak, Kaseya warned, has not yet arrived.
Still, there are signs of a shift. The African Epidemic Fund has secured roughly $80 million in pledges from African governments, and a broader donor conference this week generated approximately $910 million in commitments. South African President Ramaphosa is scheduled to visit both Ituri and Uganda next week to help mobilize further resources. Whether the money and political will can move fast enough to match the virus remains the defining question — but Africa's leadership has made clear it is no longer willing to wait for answers to come from elsewhere.
In the eastern provinces of Congo and Uganda, a virus is spreading faster than the systems meant to contain it. Since mid-May, Ebola has confirmed itself in 894 people and killed more than 200 of them. The actual toll is almost certainly higher—the outbreak went unrecognized for weeks before anyone sounded the alarm. Health workers in Ituri province, in Congo's east, are burying bodies with regularity now, including the bodies of infants. They work without rest, and they work under suspicion. Residents attack them. Communities reject their warnings. The machinery of containment is grinding against profound skepticism and exhaustion.
This is the backdrop for what Africa's disease control leadership is saying must change. Jean Kaseya, the director-general of the Africa Centres for Disease Control and Prevention, has made a stark argument: the continent cannot afford to keep waiting for the world to rescue it. Speaking to journalists in Addis Ababa this week, he described the current outbreak as the worst the continent has faced at this stage of its spread. He was not making a plea for sympathy. He was making a demand for self-examination. If this same outbreak were unfolding in Europe or North America, he said, a vaccine would already exist. A treatment would already be in development. The difference is not biology. It is investment and will.
The numbers that frame this crisis are stark and structural. Africa, home to a population that will reach 2.5 billion by 2050, manufactures less than one percent of the vaccines it needs and three percent of its medicines. The continent is perpetually dependent, perpetually vulnerable, perpetually waiting. Kaseya's message was blunt: this dependency is a choice, and it can be unmade. "We don't want to be a continent begging every day," he said. "We want to be a continent of people who know what they are doing and who are respected because they are doing the right thing."
The current outbreak presents a particular challenge because it is caused by the Bundibugyo virus, for which no approved vaccine or treatment exists. Congo has weathered sixteen Ebola outbreaks before, but most were caused by the Zaire strain, which has a vaccine. This time, the continent is improvising in real time. Contact tracing is slow and incomplete. Officials still do not know who the first infected person was. More than 35,000 people who may have been exposed to the virus remain untraced. The peak of the outbreak, Kaseya warned, has not yet arrived.
Yet there is movement toward the independence Kaseya is advocating for. The African Epidemic Fund, newly established, has secured pledges of roughly 80 million dollars from African governments themselves. A broader international donor conference this week generated commitments of approximately 910 million dollars. South African President Cyril Ramaphosa is scheduled to travel to both Ituri and Uganda next week to help mobilize additional resources. These are not trivial sums, and they represent a shift in how the continent is thinking about its own capacity.
Still, the timeline is uncertain. Kaseya said he could not guarantee that a vaccine would be available by the end of the year. The work of finding and monitoring contacts continues to lag. The outbreak is spreading into territory where trust is fractured and where the people doing the work are themselves targets of violence. What is clear is that Africa's leadership is no longer willing to accept the old arrangement—where crises arrive and solutions come from elsewhere. The question now is whether the resources and the political will can move fast enough to match the speed of the virus itself.
Bemerkenswerte Zitate
If this outbreak was in Europe, the United States or other continents, they would already have developed a vaccine and medicine.— Jean Kaseya, Africa CDC Director-General
We need to take care of ourselves. It's time for us to really think strongly about how we can manufacture medicines and vaccines to meet our own needs.— Jean Kaseya, Africa CDC Director-General